HIGHLIGHTS
- who: Erythematosus Our and colleagues from the Rheumatology, State University of New York Downstate Health Sciences University, Brooklyn, USA have published the article: Review began 01/02/2023 Review ended 01/19/2023 Published 01/30/2023 u00a9 Copyright, in the Journal: (JOURNAL) of January/30,/2023
- what: The aim of this study was to describe practice using MMF with regard to its indications safety tolerability and treatment efficacy. In this retrospective chart review the authors identified all patients treated with MMF between 1999 and 2019.
SUMMARY
Mycophenolate mofetil (MMF) was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.